Pfizer testing a drug to fight COVID if detected early

Published September 28, 2021 7:14 AM

(KYMA, KECY) - A new antiviral pill could fight COVID-19 early after diagnosis.

Pfizer is now testing the drug, which could possibly even prevent symptoms, and limit transmission to people in a patient's household.

There are at least three antivirals for covid being tested in clinical trials.

Results could come as soon as late fall or winter.

The top contender is a medication from Merck and Company and Ridgeback Biotherapeutics.

There's also one from Pfizer, and another from Roche and Atea Pharmaceuticals.

Article Topic Follows: Coronavirus

Jump to comments ↓

April Hettinger

April was born and raised in San Diego where she loved the beach town and her two dogs, Lexi and Malibu. She decided to trade the beach for the snow and advanced her education at Northern Arizona University in Flagstaff.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.